Hello, and welcome to the Robert Half Second Quarter 2026 Conference Call. Today's conference call is being recorded. [Operator Instructions] Our hosts for today's call are Mr. Keith Waddell, ...

Replimune Group faces a pivotal FDA decision for RP1 in advanced melanoma, with a Sell rating reflecting approval odds and the current price. Learn more about REPL stock here.

What if retirement is still decades away? We asked financial experts for advice about saving for retirement in a way that ...

China’s struggling housing sector will see a sharper downturn this year than previously thought, marking the fifth consecutive year of decline and pushing back any hopes for recovery, according to a ...